DE69413405D1 - 1,5-benzodiazepin-derivate verwendbar als cck oder gastrin antagonisten - Google Patents

1,5-benzodiazepin-derivate verwendbar als cck oder gastrin antagonisten

Info

Publication number
DE69413405D1
DE69413405D1 DE69413405T DE69413405T DE69413405D1 DE 69413405 D1 DE69413405 D1 DE 69413405D1 DE 69413405 T DE69413405 T DE 69413405T DE 69413405 T DE69413405 T DE 69413405T DE 69413405 D1 DE69413405 D1 DE 69413405D1
Authority
DE
Germany
Prior art keywords
gastrine
cck
antagonists
derivatives used
benzodiazepine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69413405T
Other languages
English (en)
Other versions
DE69413405T2 (de
Inventor
Daniele Donati
Antonella Ursini
Mauro Corsi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
Glaxo Wellcome SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome SpA filed Critical Glaxo Wellcome SpA
Publication of DE69413405D1 publication Critical patent/DE69413405D1/de
Application granted granted Critical
Publication of DE69413405T2 publication Critical patent/DE69413405T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/121,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69413405T 1993-07-20 1994-07-18 1,5-benzodiazepin-derivate verwendbar als cck oder gastrin antagonisten Expired - Fee Related DE69413405T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939314981A GB9314981D0 (en) 1993-07-20 1993-07-20 Chemical compounds
PCT/EP1994/002353 WO1995003285A1 (en) 1993-07-20 1994-07-18 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists

Publications (2)

Publication Number Publication Date
DE69413405D1 true DE69413405D1 (de) 1998-10-22
DE69413405T2 DE69413405T2 (de) 1999-04-15

Family

ID=10739096

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69413405T Expired - Fee Related DE69413405T2 (de) 1993-07-20 1994-07-18 1,5-benzodiazepin-derivate verwendbar als cck oder gastrin antagonisten

Country Status (32)

Country Link
US (1) US5716953A (de)
EP (1) EP0710230B1 (de)
JP (1) JP3587849B2 (de)
KR (1) KR100347287B1 (de)
CN (1) CN1050835C (de)
AP (1) AP492A (de)
AT (1) ATE171167T1 (de)
AU (1) AU687858B2 (de)
CA (1) CA2167308A1 (de)
CO (1) CO4290299A1 (de)
CZ (1) CZ290472B6 (de)
DE (1) DE69413405T2 (de)
DK (1) DK0710230T3 (de)
EC (1) ECSP941120A (de)
ES (1) ES2123812T3 (de)
FI (1) FI960223A (de)
GB (1) GB9314981D0 (de)
HR (1) HRP940411B1 (de)
HU (1) HU222439B1 (de)
IL (1) IL110366A (de)
IS (1) IS4190A (de)
MY (1) MY118638A (de)
NO (1) NO313288B1 (de)
NZ (1) NZ271075A (de)
PE (1) PE8295A1 (de)
PL (1) PL175609B1 (de)
RU (1) RU2135485C1 (de)
SI (1) SI0710230T1 (de)
SV (1) SV1994000031A (de)
TW (1) TW290542B (de)
WO (1) WO1995003285A1 (de)
ZA (1) ZA945238B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739129A (en) * 1994-04-14 1998-04-14 Glaxo Wellcome Inc. CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
WO1998002419A1 (fr) * 1996-07-12 1998-01-22 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs de proliferation de cellules cancereuses
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US6958330B1 (en) 1998-06-22 2005-10-25 Elan Pharmaceuticals, Inc. Polycyclic α-amino-ε-caprolactams and related compounds
US6569851B1 (en) 1998-06-22 2003-05-27 Elan Pharmaceutials, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
TR200201026T2 (tr) 1999-10-15 2002-08-21 F.Hoffmann-La Roche Ag Benzodiazepin türevleri
US20050192265A1 (en) * 2003-03-20 2005-09-01 Thompson Richard C. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
CA2813136A1 (en) * 2004-02-27 2005-09-15 Aortx, Inc. Prosthetic heart valve delivery systems and methods
EP2137167B1 (de) * 2007-04-19 2011-08-10 F. Hoffmann-La Roche AG Dihydro-benzo[b][1,4]diazepin-2-on-sulfonamidderivate
RU2540464C2 (ru) * 2012-05-28 2015-02-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Водорастворимое производное амида салициловой кислоты, обладающее транквилизирующей, ноотропной и анальгезирующей активностью
CN103435562B (zh) * 2013-08-26 2016-02-24 华东理工大学 6-取代苯并二氮卓-2,4-二酮类化合物及其用途
RU2702359C1 (ru) * 2019-06-04 2019-10-08 Федеральное государственное бюджетное научное учреждение Уфимский федеральный исследовательский центр Российской академии наук Способ получения 2,2,4-триалкил-2,3-дигидро-1Н-1,5-бензодиазепинов

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
CA2068355A1 (en) * 1991-05-14 1992-11-15 Mark S. Chambers Benzodiazephine derivatives, compositions containing them and their use in therapy
GEP20001968B (en) * 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents
GB9201181D0 (en) * 1992-01-21 1992-03-11 Glaxo Spa Chemical compounds
GB9225492D0 (en) * 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives

Also Published As

Publication number Publication date
ATE171167T1 (de) 1998-10-15
AP9400657A0 (en) 1994-07-31
HRP940411B1 (en) 2000-12-31
US5716953A (en) 1998-02-10
JPH09502428A (ja) 1997-03-11
AU7458994A (en) 1995-02-20
FI960223A0 (fi) 1996-01-17
ECSP941120A (es) 1995-01-16
PL175609B1 (pl) 1999-01-29
GB9314981D0 (en) 1993-09-01
NO313288B1 (no) 2002-09-09
HU222439B1 (hu) 2003-07-28
NZ271075A (en) 1998-06-26
DE69413405T2 (de) 1999-04-15
IL110366A (en) 1999-01-26
ES2123812T3 (es) 1999-01-16
AP492A (en) 1996-05-13
CN1138853A (zh) 1996-12-25
ZA945238B (en) 1995-02-09
HU9600124D0 (en) 1996-03-28
TW290542B (de) 1996-11-11
EP0710230B1 (de) 1998-09-16
IL110366A0 (en) 1994-10-21
RU2135485C1 (ru) 1999-08-27
CA2167308A1 (en) 1995-02-02
KR100347287B1 (ko) 2002-12-06
PL312659A1 (en) 1996-04-29
SI0710230T1 (en) 1999-02-28
CO4290299A1 (es) 1996-04-17
PE8295A1 (es) 1995-04-20
MY118638A (en) 2004-12-31
CZ290472B6 (cs) 2002-07-17
AU687858B2 (en) 1998-03-05
DK0710230T3 (da) 1999-06-14
EP0710230A1 (de) 1996-05-08
WO1995003285A1 (en) 1995-02-02
HRP940411A2 (en) 1997-04-30
JP3587849B2 (ja) 2004-11-10
IS4190A (is) 1995-01-21
FI960223A (fi) 1996-03-19
HUT73499A (en) 1996-08-28
CN1050835C (zh) 2000-03-29
CZ17396A3 (en) 1996-07-17
NO960237D0 (no) 1996-01-19
NO960237L (no) 1996-03-19
SV1994000031A (es) 1995-10-04

Similar Documents

Publication Publication Date Title
FI954853A0 (fi) 1,5-bentsodiatsepiinijohdannaisia, joilla on CCK-antagonistinen tai agonistinen aktiivisuus
DK0805813T3 (da) Tricyclic vasopressin antagonists
FI953489A0 (fi) 2,6-diaminopuriinijohdannaisia
DE69422756T2 (de) Elektrophotographische Arbeitseinheit
DK0804440T3 (da) Tricykliske benzazapin-vasopressionantagonister
DE69204040T2 (de) 3-Phenylureido-1,4-Benzodiazepinone und ihre Verwendung als Cholecystokinin- oder Gastrinantagonisten.
DE69413405D1 (de) 1,5-benzodiazepin-derivate verwendbar als cck oder gastrin antagonisten
DE59400664D1 (de) Mehrzweckkalander
GB9217475D0 (en) Nauroprotective use cck antagonists
FI974434A (fi) Trisyklisiä 5,6-dihydro-9H-pyratsolo(3,4-c)-1,2,4,-triatsolo(4,3-alfapidiinejä
FI954852A (fi) 1,5-bentsodiatsepiinijohdannaisia, joilla on CCK- ja/tai gastriiniantagonistinen aktiivisuus
MC2312A1 (fr) Antagonistes de la bombesine
NO933506D0 (no) Ioderte fuktemidler
AU7228994A (en) 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
FI943656A0 (fi) Lajittelija
NO944024L (no) 1,2-dihydro-2-okso-pyridin
NO943791D0 (no) 1,2-dihydro-2-okso-3-metylsulfonylaminometylpyridin
NO942212D0 (no) 13,14-dihydro-PGF2
KR950006613U (ko) 고리잠금쇠
DE9413808U1 (de) Mehrzweckprofil
LV10616A (lv) Aizvietoti ciklopropilamino-1,3,5-triazini
DE9320557U1 (de) Schieberiegel-Sicherung
DE9315916U1 (de) Galvanisiertrommel
ITPA930019A0 (it) Profilato polivalente.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee